Beijing CollaRegen is a biotechnology company specializing in the development of functional proteins. We are dedicated to building China's first full-length human gene-based macromolecular protein platform. The company has achieved a major breakthrough in the development of next-generation biomaterials based on full-length human collagen. We have successfully completed the world's first large-scale production of full-length Type II and Type III human collagen expressed in mammalian cells. Compared with existing recombinant humanized collagen products, these innovations represent a significant technological advancement in terms of molecular weight, amino acid sequence fidelity, preservation of the native triple-helical structure, and expression system. This breakthrough marks a major milestone in advancing collagen as a foundational biomaterial for constructing extracellular matrix (ECM) scaffolds.